Mesoblast Limited

Mesoblast Limitedverified

MESO

Price:

$13.93

Market Cap:

$1.78B

Mesoblast Limited is a biopharmaceutical firm dedicated to the development and commercialization of allogeneic cell-based therapies. Its global presence extends across the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company addresses a broad spectrum of medical conditions, including cardiovascular, spinal orthopedic disorders, oncology, hematology, and immune-mediated and inflammatory diseases. At the core of its innovation is a proprietary regenerative medicine platform utilizing specialized mesenchymal lineage cells. Currently, several of Mesoblast's leading product candidates are undergoing Phase III clinical trials: remestemcel-L, designed for severe, st...[Read more]

Industry

Biotechnology

IPO Date

2010-01-20

Stock Exchange

NASDAQ

Ticker

MESO

The Enterprise Value as of June 2026 (TTM) for Mesoblast Limited (MESO) is 1.79B

According to Mesoblast Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 1.79B. This represents a change of 424.93% compared to the average of 340.80M of the last 4 quarters.

Mesoblast Limited (MESO) Historical Enterprise Value (quarterly & annually)

How has MESO Enterprise Value performed in the past?

The mean historical Enterprise Value of Mesoblast Limited over the last ten years is 700.17M. The current 1.79B Enterprise Value has changed 25.45% with respect to the historical average. Over the past ten years (40 quarters), MESO's Enterprise Value was at its highest in in the December 2024 quarter at 2.28B. The Enterprise Value was at its lowest in in the September 2025 quarter at 0.

Quarterly (TTM)
Annual

Average

700.17M

Median

646.14M

Minimum

305.83M

Maximum

1.21B

Mesoblast Limited (MESO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Mesoblast Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 107.54%

Maximum Annual Enterprise Value = 1.21B

Minimum Annual Increase = -73.32%

Minimum Annual Enterprise Value = 305.83M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20251.21B70.08%
2024713.46M23.70%
2023576.75M88.59%
2022305.83M-62.77%
2021821.52M-26.20%
20201.11B107.54%
2019536.33M-7.34%
2018578.82M-23.81%
2017759.69M98.49%
2016382.73M-73.32%

Mesoblast Limited (MESO) Average Enterprise Value

How has MESO Enterprise Value performed in the past?

The current Enterprise Value of Mesoblast Limited (MESO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

834.55M

5-year avg

726.20M

10-year avg

700.17M

Mesoblast Limited (MESO) Enterprise Value vs. Peers

How is MESO’s Enterprise Value compared to its peers?

Mesoblast Limited’s Enterprise Value is greater than Ocular Therapeutix, Inc. (1.37B), less than Edgewise Therapeutics, Inc. (3.72B), greater than Galapagos N.V. (1.58B), less than Structure Therapeutics Inc. (2.16B), greater than uniQure N.V. (1.66B), greater than Viridian Therapeutics, Inc. (1.35B), less than Liquidia Corporation (6.30B), greater than Nuvation Bio Inc. (1.59B), less than ImmunityBio, Inc. (8.36B), less than Cogent Biosciences, Inc. (5.65B),

Build a custom stock screener for Mesoblast Limited (MESO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mesoblast Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mesoblast Limited (MESO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mesoblast Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Mesoblast Limited's Enterprise Value?

What is the highest Enterprise Value for Mesoblast Limited (MESO)?

What is the 3-year average Enterprise Value for Mesoblast Limited (MESO)?

What is the 5-year average Enterprise Value for Mesoblast Limited (MESO)?

How does the current Enterprise Value for Mesoblast Limited (MESO) compare to its historical average?